Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis
Open Access
- 1 January 2009
- journal article
- review article
- Published by Springer Nature in International Archives of Medicine
- Vol. 2 (1) , 30
Abstract
While hypertension is a leading risk factor for an initial stroke, the role of blood pressure lowering to prevent subsequent stroke is less clear. The results of recent large clinical trials investigating effects of antihypertensive agents in patients with a history of stroke have not shown a significant benefit; findings that are at odds with previous data. Our meta-analysis systematically evaluates the available, relevant trials to examine the role of antihypertensive drugs in preventing recurrent stroke.Keywords
This publication has 35 references indexed in Scilit:
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular EventsNew England Journal of Medicine, 2008
- Drug Therapy for the Secondary Prevention of Stroke in Hypertensive PatientsDrugs, 2007
- Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic AttackStroke, 2006
- Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary PreventionStroke, 2005
- Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular EventsStroke, 2003
- Cause-Specific Mortality After First Cerebral InfarctionStroke, 2003
- The ACCESS StudyStroke, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group.Stroke, 1993
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990